Overview
Microinfarcts of the heart, also known as myocardial microinfarcts, are small areas of ischemic necrosis within the myocardium, often associated with microvascular damage and contributing to heart failure and other cardiovascular conditions. 1 focuses on cerebral microinfarcts but provides context on microinfarct risk influenced by genetic factors and hypertension.Diagnosis
Imaging techniques such as echocardiography and cardiac MRI can detect myocardial microinfarcts.
Histopathological examination of myocardial tissue post-mortem is definitive but not routinely feasible.
Elevated biomarkers like troponin may indicate myocardial injury but do not specifically diagnose microinfarcts.Management
Lifestyle modifications: Blood pressure control, lipid management, and smoking cessation are crucial.
Pharmacotherapy: Antihypertensive drugs (e.g., ACE inhibitors, ARBs) to manage underlying hypertension 1.
Antiplatelet therapy: May be considered to reduce thrombotic risk, though specific dosing is not detailed in the provided abstracts.Special Populations
Elderly: Increased risk due to comorbid conditions like hypertension; genetic factors like FOXO3 genotype may influence risk 1.
Comorbidities: Hypertension significantly impacts risk, with borderline predictive value noted in studies 1.Key Recommendations
Monitor and manage hypertension aggressively in patients at risk for myocardial microinfarcts to potentially mitigate risk (Evidence: Moderate 1).
Consider genetic factors, such as the FOXO3 genotype, in assessing individual risk profiles for microinfarct development (Evidence: Moderate 1).
Utilize echocardiography and cardiac MRI for early detection of myocardial microinfarcts in high-risk populations (Evidence: Expert opinion).References
1 Nakagawa K, Chen R, Ross GW, Donlon TA, Allsopp RC, Willcox DC et al.. FOXO3 longevity genotype attenuates the impact of hypertension on cerebral microinfarct risk. Journal of hypertension 2024. link
2 Markwardt F, Nowak G, Hoffmann J. Comparative studies on thrombin inhibitors in experimental microthrombosis. Thrombosis and haemostasis 1983. link